Drugs · acquisition-cost intelligence
Arnuity Ellipta
fluticasone furoate· ingredient fluticasoneCorticosteroids· FLUTICASONE FUROATE 100 ug/1; FLUTICASONE FUROATE 200 ug/1; FLUTICASONE FUROATE 50 ug/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$6.65
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other fluticasone products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| fluticasone propionate | $0.35931 | −$6.29 |
| Fluticasone Propionate | $0.56876 | −$6.08 |
| 24 Hour Allergy Nasal | $0.68437 | −$5.97 |
| FLOVENT DISKUS | $2.12 | −$4.54 |
| fluticasone propionate | $3.14 | −$3.52 |
| Fluticasone Propionate HFA | $12.55 | +$5.90 |
Medicare Part D coverage · CY2026
On 6 plan formularies · typical tier 1
Prior auth 0% · Step therapy 0% · Quantity limit 33% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.